By the end of 2023, approximately 40 million people worldwide were living with human immunodeficiency virus (HIV), including 1.4 million children under 15 years of age [1]. Global trends indicate a significant decline in new HIV infections among children aged 0–9 years [1]. Concurrently, the number of annual acquired immune deficiency syndrome (AIDS)-related deaths among children has decreased by 75% since its peak in 2002 [1]. As a result, many of these children living with HIV have transitioned into adolescence and adulthood.
Cancer in children living with HIV: challenges and perspectives in the antiretroviral therapy era / Chiappini E.; Costantino A.; Masci D.; Petrara M.R.; Galli L.; De Rossi A.. - In: WORLD JOURNAL OF PEDIATRICS. - ISSN 1708-8569. - ELETTRONICO. - 21:(2025), pp. 1184-1195. [10.1007/s12519-025-00971-x]
Cancer in children living with HIV: challenges and perspectives in the antiretroviral therapy era
Chiappini E.
;Costantino A.;Masci D.;Galli L.;
2025
Abstract
By the end of 2023, approximately 40 million people worldwide were living with human immunodeficiency virus (HIV), including 1.4 million children under 15 years of age [1]. Global trends indicate a significant decline in new HIV infections among children aged 0–9 years [1]. Concurrently, the number of annual acquired immune deficiency syndrome (AIDS)-related deaths among children has decreased by 75% since its peak in 2002 [1]. As a result, many of these children living with HIV have transitioned into adolescence and adulthood.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
